Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-042410
Filing Date
2007-02-28
Accepted
2007-02-28 14:37:13
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1173369
2 VIROPHARMA BONUS PLAN dex1022.htm EX-10.22 24982
3 AGREEMENT OF SALE dex1033.htm EX-10.33 55693
4 SUBSIDIARIES OF THE COMPANY dex21.htm EX-21 2092
5 CONSENT dex23.htm EX-23 2616
6 CERIFICATION dex311.htm EX-31.1 9379
7 CERTIFICATION dex312.htm EX-31.2 9284
8 CERTIFICATION dex321.htm EX-32.1 4512
  Complete submission text file 0001193125-07-042410.txt   1283297
Mailing Address 397 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 397 EAGLEVIEW BLVD EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 07657001
SIC: 2834 Pharmaceutical Preparations